Published in Gan To Kagaku Ryoho on November 01, 2009
Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2010 for the treatment of colorectal cancer. Int J Clin Oncol (2011) 5.39
Fluorouracil versus combination of irinotecan plus cisplatin versus S-1 in metastatic gastric cancer: a randomised phase 3 study. Lancet Oncol (2009) 5.19
Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study). Lancet Oncol (2010) 2.73
Phase II study of chemoradiotherapy with 5-fluorouracil and cisplatin for Stage II-III esophageal squamous cell carcinoma: JCOG trial (JCOG 9906). Int J Radiat Oncol Biol Phys (2010) 1.71
Phase II study of paclitaxel with 3-h infusion in patients with advanced gastric cancer. Gastric Cancer (2002) 1.71
Multicenter phase II study of everolimus in patients with previously treated metastatic gastric cancer. J Clin Oncol (2010) 1.69
Pharmacodynamic studies of gefitinib in tumor biopsy specimens from patients with advanced gastric carcinoma. J Clin Oncol (2006) 1.34
Phase I/II study of capecitabine plus oxaliplatin (XELOX) plus bevacizumab as first-line therapy in Japanese patients with metastatic colorectal cancer. Jpn J Clin Oncol (2010) 1.16
Efficacy of trastuzumab in Japanese patients with HER2-positive advanced gastric or gastroesophageal junction cancer: a subgroup analysis of the Trastuzumab for Gastric Cancer (ToGA) study. Gastric Cancer (2011) 1.08
Epidermal growth factor receptor is a possible predictor of sensitivity to chemoradiotherapy in the primary lesion of esophageal squamous cell carcinoma. Jpn J Clin Oncol (2007) 1.08
Phase I and pharmacokinetic study of S-1 combined with weekly paclitaxel in patients with advanced gastric cancer. Oncology (2005) 1.02
Phase II study of a combination of S-1 and paclitaxel in patients with unresectable or metastatic gastric cancer. Oncology (2008) 0.98
A phase 2 clinical trial of panitumumab monotherapy in Japanese patients with metastatic colorectal cancer. Jpn J Clin Oncol (2009) 0.93
A phase II Study of the global dose and schedule of capecitabine in Japanese patients with metastatic colorectal cancer. Jpn J Clin Oncol (2006) 0.93
A multicenter phase II study of biweekly paclitaxel and S-1 combination chemotherapy for unresectable or recurrent gastric cancer. Cancer Chemother Pharmacol (2008) 0.92
Phase II study of a combination of irinotecan and S-1 in patients with advanced gastric cancer (OGSG0002). Oncology (2008) 0.92
Efficacy and safety of capecitabine plus cisplatin in Japanese patients with advanced or metastatic gastric cancer: subset analyses of the AVAGAST study and the ToGA study. Gastric Cancer (2012) 0.92
Evaluation of prognostic factors of esophageal squamous cell carcinoma (stage II-III) after concurrent chemoradiotherapy using biopsy specimens. Jpn J Clin Oncol (2007) 0.90
A phase II study of paclitaxel by weekly 1-h infusion for advanced or recurrent esophageal cancer in patients who had previously received platinum-based chemotherapy. Cancer Chemother Pharmacol (2010) 0.88
Multicenter Phase II study of cetuximab plus irinotecan in metastatic colorectal carcinoma refractory to irinotecan, oxaliplatin and fluoropyrimidines. Jpn J Clin Oncol (2008) 0.88
Phase II study of docetaxel, cisplatin and 5-fluorouracil (DCF) for metastatic esophageal cancer (OGSG 0403). Anticancer Res (2012) 0.86
Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets. Jpn J Clin Oncol (2004) 0.84
A multicenter phase II study of the stop-and-go modified FOLFOX6 with bevacizumab for first-line treatment of patients with metastatic colorectal cancer. Invest New Drugs (2011) 0.81
Phase II study of S-1 monotherapy in patients over 75 years of age with advanced gastric cancer (OGSG0404). J Chemother (2013) 0.81
[Case of disseminated carcinomatosis of bone marrow with severe alkalinephosphatasia, manifested 10 years after resection of early gastric cancer]. Nihon Shokakibyo Gakkai Zasshi (2004) 0.80
Phase II study of biweekly paclitaxel and cisplatin combination chemotherapy in advanced gastric cancer: Korea Japan Collaborative Study Group Trial. Jpn J Clin Oncol (2007) 0.79
Irinotecan is inactive as a first-line treatment, but plays an important part in gastric cancer treatment. Gastric Cancer (2011) 0.79
A phase I study of triplet combination chemotherapy of paclitaxel, cisplatin and S-1 in patients with advanced gastric cancer. Jpn J Clin Oncol (2012) 0.78
[Combination of S-1 and paclitaxel for advanced/recurrent gastric cancer patients with peritoneal metastasis, feasibility study (OGSG0401)]. Gan To Kagaku Ryoho (2010) 0.78
[Weekly administration regimen of paclitaxel (PTX) in patient with inoperable or recurrent gastric cancer]. Gan To Kagaku Ryoho (2006) 0.77
Adjuvant therapy in rectal cancer: what is the truth? Jpn J Clin Oncol (2006) 0.77
Gastric mucosal cell protection by epidermal growth factor in primary monolayer culture of guinea pig gastric mucous cells. J Gastroenterol (2003) 0.77
A randomized phase II selection trial in patients with advanced/recurrent gastric cancer: Trial for Advanced Stomach Cancer (TASC). Jpn J Clin Oncol (2007) 0.75
Application of electrolysis for detoxification of an antineoplastic in urine. Ecotoxicol Environ Saf (2011) 0.75
[A case of gastric cancer with multiple liver metastases resistant to TS-1 responding to chemotherapy with paclitaxel plus doxifluridine]. Gan To Kagaku Ryoho (2006) 0.75
Metastatic malignant melanoma. Gastrointest Endosc (2002) 0.75
[Serotonin syndrome in a patient with small cell lung cancer]. Gan To Kagaku Ryoho (2013) 0.75
[A resected case of effective treatment with S-1+CPT-11 combination chemotherapy for advanced gastric cancer]. Gan To Kagaku Ryoho (2010) 0.75
[Chemotherapy for gastrointestinal cancer in elderly patients]. Gan To Kagaku Ryoho (2011) 0.75
[A case of advanced gastric cancer with DIC treated by sequential MTX and 5-FU]. Gan To Kagaku Ryoho (2004) 0.75
[Lower G. I./colon and rectum cancer. IV. Standard chemotherapy of advanced, recurrent colonic cancer]. Gan To Kagaku Ryoho (2010) 0.75
[Phase I / II study of XELOX plus bevacizumab in Japanese patients with metastatic colorectal cancer(JO19380)]. Gan To Kagaku Ryoho (2011) 0.75
Phase II study of combination chemotherapy with biweekly cetuximab and irinotecan for pre-treated metastatic colorectal cancer harboring wild-type KRAS. Jpn J Clin Oncol (2010) 0.75
[Comparison of chemotherapy side effects between elderly and young subjects]. Gan To Kagaku Ryoho (2012) 0.75
Evaluation of an electrolysis apparatus for inactivating antineoplastics in clinical wastewater. Chemosphere (2008) 0.75
[Current status and perspectives of biologics in the treatment of metastatic colorectal cancer]. Nihon Rinsho (2010) 0.75
[Effectiveness of chemotherapy for outpatients with gastric or colorectal cancer]. Gan To Kagaku Ryoho (2002) 0.75
[S-1 combined with weekly paclitaxel in patients with advanced gastric cancer]. Gan To Kagaku Ryoho (2006) 0.75
Phase I/II study of CPT-11 plus UFT in patients with advanced/recurrent colorectal cancer: Osaka Gastrointestinal Cancer Chemotherapy Study Group (OGSG): Protocol 0102. Jpn J Clin Oncol (2007) 0.75
A problem-based learning tutorial for dental students regarding elderly residents in a nursing home in Japan. J Dent Educ (2012) 0.75